Literature DB >> 9785145

Behavioral disturbances and pharmacological treatment of patients with dementia in family caregiving: a 2-year follow-up.

S Elmståhl1, I Stenberg, L Annerstedt, B Ingvad.   

Abstract

Behavioral disturbances are common in dementia. Polypharmacy due to progression of disease and fluctuation of symptoms among patients might increase risk of overtreatment and/or undertreatment. Drug prescription habits were studied in relationship to symptoms of dementia after relocation of patients to group-living care units (GC). Seventy-six demented patients (mean age 81 years) were assessed before, 12 months after, and 24 months after relocation to GC. Vascular dementia was found in 47%, Alzheimer's dementia in 46%, and other dementias in 7%. Medications, regular or as required, were recorded from medication lists. Repeated observations of symptoms like depressive mood and lack of vitality were made with validated scales. Eighty percent of the patients were prescribed drugs; 40% were given neuroleptics and 9% were given antidepressants. During the 2-year follow-up, polypharmacy increased; patients with five drugs or more increased from 15% to 35%; usage of neuroleptics or sedatives, as required, increased from 8% to 25%, p < .01. Depressive mood was noted in 86% after 2 years and 74% showed aggressiveness and anxiety, but only 12% of the patients with depressive symptoms were on antidepressants. Analgesics were prescribed to 26% of patients. In conclusion, a high proportion of patients with dementia had depressive mood and undertreatment of depressive disorder might be suspected. Polypharmacy increased during the 2-year follow-up; this finding calls for careful monitoring of adverse drug reactions, because of the deteriorating cognitive function of these patients.

Entities:  

Mesh:

Year:  1998        PMID: 9785145     DOI: 10.1017/s1041610298005353

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  10 in total

1.  Psychotropic drugs in nursing- and old-age homes: relationships between needs of care and mental health status.

Authors:  Ing-Britt Holmquist; Bengt Svensson; Peter Höglund
Journal:  Eur J Clin Pharmacol       Date:  2003-09-27       Impact factor: 2.953

2.  Use of psychotropic drugs in elderly nursing home residents with and without dementia in Helsinki, Finland.

Authors:  Helka Hosia-Randell; Kaisu Pitkälä
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 3.  Polypharmacy and inappropriate medication use in patients with dementia: an underresearched problem.

Authors:  Carole Parsons
Journal:  Ther Adv Drug Saf       Date:  2016-10-01

Review 4.  Sleep disturbances in patients with Alzheimer's disease: epidemiology, pathophysiology and treatment.

Authors:  M V Vitiello; S Borson
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

5.  Small-scale, homelike facilities versus regular psychogeriatric nursing home wards: a cross-sectional study into residents' characteristics.

Authors:  Hilde Verbeek; Sandra M G Zwakhalen; Erik van Rossum; Ton Ambergen; Gertrudis I J M Kempen; Jan P H Hamers
Journal:  BMC Health Serv Res       Date:  2010-01-29       Impact factor: 2.655

Review 6.  Circadian rhythm sleep disorders: part II, advanced sleep phase disorder, delayed sleep phase disorder, free-running disorder, and irregular sleep-wake rhythm. An American Academy of Sleep Medicine review.

Authors:  Robert L Sack; Dennis Auckley; R Robert Auger; Mary A Carskadon; Kenneth P Wright; Michael V Vitiello; Irina V Zhdanova
Journal:  Sleep       Date:  2007-11       Impact factor: 5.849

7.  How Clinicians Discuss Medications During Primary Care Encounters Among Older Adults with Cognitive Impairment.

Authors:  Ariel R Green; Jennifer L Wolff; Diane M Echavarria; Malcolm Chapman; Annie Phung; Devon Smith; Cynthia M Boyd
Journal:  J Gen Intern Med       Date:  2019-11-08       Impact factor: 5.128

8.  Use of Potentially Harmful Medications and Health-Related Quality of Life among People with Dementia Living in Residential Aged Care Facilities.

Authors:  Pascalle R Bosboom; Helman Alfonso; Osvaldo P Almeida; Christopher Beer
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2012-09-07

9.  Severe psychiatric disorders in mid-life and risk of dementia in late- life (age 65-84 years): a population based case-control study.

Authors:  Renate R Zilkens; David G Bruce; Janine Duke; Katrina Spilsbury; James B Semmens
Journal:  Curr Alzheimer Res       Date:  2014       Impact factor: 3.498

10.  Polysomnographic assessment of suvorexant in patients with probable Alzheimer's disease dementia and insomnia: a randomized trial.

Authors:  W Joseph Herring; Paulette Ceesay; Ellen Snyder; Donald Bliwise; Kerry Budd; Jill Hutzelmann; Joanne Stevens; Christopher Lines; David Michelson
Journal:  Alzheimers Dement       Date:  2020-01-15       Impact factor: 21.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.